Albuminuria and transferrinuria in essential hypertension: Effects of antihypertensive therapy

American Journal of Hypertension

Volumn 9, Issue 11, 1996, Pages 1068-1076

  Alli, Claudio ^a,b   Lombardo, Michele ^a   Zanni, Daniela ^a   Agrati, Antonio Maria ^a   Cassani, Mario ^a   Granata, Simonetta ^a  

^a OSPEDALE NIGUARDA CA GRANDA   (Italy)

^b NONE   (Italy)

Author keywords

Albuminuria; Amlodipine; Essential hypertension; Fosinopril; Transferrinuria

Indexed keywords

ALBUMIN; AMLODIPINE; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FOSINOPRIL; TRANSFERRIN;

ADULT; AMBULATORY MONITORING; ARTICLE; BLOOD PRESSURE MEASUREMENT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EDEMA; ESSENTIAL HYPERTENSION; FEMALE; HUMAN; KIDNEY FUNCTION; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROTEINURIA; RANDOMIZED CONTROLLED TRIAL; TRANSFERRINURIA;

ADULT; ALBUMINURIA; AMLODIPINE; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; CALCIUM CHANNEL BLOCKERS; FEMALE; FOSINOPRIL; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; TRANSFERRIN;

EID: 0029804005     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/0895-7061(96)00237-3     Document Type: Article

References (54)

1. Viberti GC, Jarrett RJ, Mahmud U, et al: Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet 1982;i:1430-1432.
2. Mogensen CE: Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N Engl J Med 1984;310:356-360.
3. Messent JWC, Elliott TG, Hill RD, et al: Prognostic significance of microalbuminuria in insulin-dependent diabetes mellitus: a twenty-three year follow-up. Kidney Int 1992;41:836-839.
4. Damsgaard EM, Froland A, Jorgensen OD, Mogensen CE: Microalbuminuria as predictor of increased mortality in elderly people. Br Med J 1990;300:297-300.
5. Yudkin JS, Forrest RD, Jackson CA: Microalbuminuria as predictor of vascular disease in non-diabetic subjects. Lancet 1988;ii:530-533.
6. Bianchi S, Bigazzi R, Valtriani C, et al: Elevated serum insulin levels in patients with essential hypertension and microalbuminuria. Hypertension 1994;23(part 1):681-687.
7. Mimran A, Ribstein J, DuCailar G: Is microalbuminuria a marker of early intrarenal vascular dysfunction in essential hypertension? Hypertension 1994;23(part 2):1018-1021.
8. Pedrinelli R, Gianpietro O, Carmassi F, et al: Microalbuminuria and endothelial dysfunction in essential hypertension. Lancet 1994;344:14-18.
9. Mimran A, Insua A, Ribstein J, et al: Contrasting effects of captopril and nifedipine in normotensive patients with incipient diabetic nephropathy. J Hypertens 1988; 6:919-923.
10. Chan JCN, Cockram CS, Nicholls MG, et al: Comparison of enalapril and nifedipine in treating non-insulin dependent diabetes associated with hypertension: one year analysis. Br Med J 1992;305:981-985.
11. Melbourne Diabetic Nephropathy Study Group: Comparison between perindopril and nifedipine in hypertensive and normotensive diabetic patients with microalbuminuria. Br Med J 1991;302:210-216.
12. Hallab M, Gallois Y, Chatellier G, et al: Comparison of reduction in microalbuminuria in enalapril and hydrochlorothiazide in normotensive patients with insulin dependent diabetes. Br Med J 1993;306:175-182.
13. Marre M, Chatellier G, Leblanc H, et al: Prevention of diabetic nephropathy with enalapril in normotensive diabetics with microalbuminuria. Br Med J 1988; 297:1092-1095.
14. Marre M, Hallab M, Billiard A, et al: Small doses of ramipril to reduce microalbuminuria in diabetic patients with incipient nephropathy independently of blood pressure changes. J Cardiovasc Pharmacol 1990; 18(suppl 2):S165-S168.
15. Marre M, Leblanc H, Suarez L, et al: Converting enzyme inhibition and kidney function in normotensive diabetic patients with persistent microalbuminuria. Br Med J 1987;294:1448-1452.
16. Viberti GC, Mogensen CE, Groop LC, Pauls JF, for the European Microalbuminuria Captopril Study Group: Effect of captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes mellitus and microalbuminuria. JAMA 1994;271:275-279.
17. Flack JR, Molyneaux L, Willey K, Yue DK: Regression of microalbuminuria: results of a controlled study, indapamide versus captopril. J Cardiovasc Pharmacol 1993;22(suppl 6):S75-S77.
18. Bianchi S, Bigazzi R, Baldari G, Campese VM: Microalbuminuria in patients with essential hypertension: effects of several antihypertensive drugs. Am J Med 1992; 93:525-528.
19. Ruilope LM, Alcazar JM, Hernandez E, et al: Long-term influences of antihypertensive therapy on microalbuminuria in essential hypertension. Kidney Int 1994; 45(suppl 45):S171-S173.
20. Krusell LR, Sihm I, Jespersen LT, et al: Renal effects of ACE-inhibition with perindopril and calcium-entry-blockade with nifedipine in essential hypertensives. A double blind cross-over study. High Blood Press 1992; 1:257-263.
21. Erley CM, Haefele U, Heyne N, et al: Microalbuminuria in essential hypertension. Reduction by different anti-hypertensive drugs. Hypertension 1993;21:810-815.
22. Martin P, Handley T, Chapman C: Urinary transferrin - an early predictor of glomerular dysfunction. Ann Clin Biochem 1988;25(suppl1):158s-159s.
23. Bernard AM, Ouled Amor AA, Goemaere-Vanneste J, et al: Microtransferrinuria is a more sensitive indicator of early glomerular damage in diabetes than microalbuminuria. Clin Chem 1988;34:1920-1921.
24. Martin P, Walton C, Chapman C, et al: Increased urinary excretion of transferrin in children with type 1 diabetes mellitus. Diabetic Med 1990;7:35-40.
25. Cheung CK, Cockram CS, Yeung VTF, Swaminathan R: Urinary excretion of transferrin by non-insulin-dependent diabetics: a marker for early complications? Clin Chem 1989;35:1672-1674.
26. Konen J, Shihabi Z, Newman J: The association of non-insulin-dependent diabetes mellitus and hypertension with urinary excretion of albumin and transferrin. Am J Kidney Dis 1993;22:791-797.
27. Meyer-Sabellek W, Schulte KL, Gotzen R: Non-invasive ambulatory blood pressure monitoring: technical possibilities and problems. J Hypertension 1990;8(suppl 6):S3-S10.
28. Appel LJ, Whelton PK, Seidler AJ, et al: The accuracy and precision of the Accutracker ambulatory blood pressure monitor. Am J Epidemiol 1990;132:343-354.
29. White WB, Dey HM, Schulman P: Assessment of the daily blood pressure load as a determinant of cardiac function in patients with mild-to-moderate hypertension. Am Heart J 1989;118:782-795.
30. Humbel RL, Schinker C, Duhoux D, Pouthier P: Immunonephelometric quantification of seven plasma proteins in human urine. J Clin Chem Clin Biochem 1988; 26:751-752.
31. Parving HH, Mogensen CE, Jensen HA, Evrin PE: Increased urinary albumin excretion rate in benign essential hypertension. Lancet 1974;i:1190-1192.
32. Losito A, Fortunati F, Zampi I, Del Favero A: Impaired renal functional reserve and albuminuria in essential hypertension. BMJ 1988;296:1562-1564.
33. Bigazzi R, Bianchi S, Campese VM, Baldari G: Prevalence of microalbuminuria in a large population of patients with mild to moderate essential hypertension. Nephron 1992;61:94-97.
34. Hoegholm A, Bang LE, Kristensen KS, et al: Microalbuminuria in 411 untreated individuals with established hypertension, white coat hypertension, and normotension. Hypertension 1994;24:101-105.
35. Stehouwer CDA, Donker AJM: Clinical usefulness of measurements of urinary albumin excretion in diabetes mellitus. Neth J Med 1993;42:175-186.
36. Schmitz A, Vaeth M: Microalbuminuria: a major risk factor in non-insulin-dependent diabetes. A 10-year follow-up study of 503 patients. Diabetic Med 1988; 5:126-134.
37. Damsgaard EM, Froland A, Jorgensen OD, Mogensen CE: Eight to nine year mortality in known non-insulin dependent diabetics and controls. Kidney Int 1992; 41:731-735.
38. Mattock MB, Morrish NJ, Viberti GC, et al: Prospective study of microalbuminuria as predictor of mortality in NIDDM. Diabetes 1992;41:736-741.
39. Tomaselli L, Trischitta V, Vinci C, et al: Evaluation of albumin excretion rate in overnight versus 24-h urine. Diabetes Care 1989;12:585-587.
40. Stehouwer CDA, Fischer HRA, Hackeng WHL, den Ottolander GJH: Identifying patients with incipient diabetic nephopathy. Should 24-hour urine collections be used? Arch Intern Med 1990;150:373-375.
41. Wiegmann TB, Chonko AM, Barnard MJ, et al: Comparison of albumin excretion rate obtained with different times collection. Diabetes Care 1990;13:864-871.
42. McKenna MJ, Arias C, Feldkamp CS, Whitehouse FW: Microalbuminuria in clinical practice. Arch Intern Med 1991;151:1745-1747.
43. Jackson B, Johnston CI: The contribution of systemic hypertension to progression of chronic renal failure in the rat remnant kidney: effect of treatment with an angiotensin converting enzyme inhibitor or a calcium inhibitor. J Hypertens 1988;6:495-501.
44. Kasiske BL, Kalil RSN, Ma JZ, Liao M, Keane WF: Effect of antihypertensive therapy on the kidney in patients with diabetes: a meta-regression analysis. Ann Intern Med 1993;118:129-138.
45. Maki DD, Ma JZ, Louis TA, Kasiske BL: Long-term effects of antihypertensive agents on proteinuria and renal function. Arch Intern Med 1995;155:1073-1080.
46. Olson JL, Wilson SK, Heptinstall RH: Relation of glomerular injury to preglomerular resistance in experimental hypertension. Kidney Int 1986;29:849-857.
47. Hollenberg NK, Raij L: Angiotensin-converting enzyme inhibition and renal protection. An assessment of implications for therapy. Arch Intern Med 1993; 153:2426-2434.
48. Valentino VA, Wilson MD, Weart W, Bakris GL: A perspective on converting enzyme inhibitors and calcium channel antagonists in diabetic renal disease. Arch Intern Med 1991;151:2367-2372.
49. Romero JC, Ruilope LM, Bentley MD, et al: Comparison of the effects of calcium antagonists and converting enzyme inhibitors on renal function under normal and hypertensive conditions. Am J Cardiol 1988;62:59G-68G.
50. Loutzenhiser RD, Epstein M: Renal hemodynamic effects of calcium antagonists. J Cardiovasc Pharmacol 1988;12(suppl 6):S48-S52.
51. Wee PM, De Micheli AG, Epstein M: Effects of calcium antagonists on renal hemodynamics and progression of nondiabetic chronic renal disease. Arch Intern Med 1994;154:1185-1202.
52. Buzio C, Regolisti G, Perazzoli F, et al: Renal effects of nifedipine and captopril in patients with essential hypertension and reduced renal reserve. Hypertension 1994;24:763-769.
53. Raij L, Luscher TF, Vanhoutte PM: High potassium diet augments endothelium-dependent relaxations in the Dahl rat. Hypertension 1988;12:562-567.
54. Konen JC, Shihabi ZK, Summerson JH: Urinary transferrin and albumin excretion in patients with mild to moderate and controlled hypertension. Clin Physiol Biochem 1993;10:1-7.